Fri, May 14, 2021

Tiago Fauth Maintained (ABCL) at Buy with Decreased Target to $51 on, May 14th, 2021

Tiago Fauth of Credit Suisse, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $53 to $51 on, May 14th, 2021.

Tiago has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tiago


  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $55 on, Tuesday, March 30th, 2021
  • Puneet Souda of "SVB Leerink" Maintained at Buy with Increased Target to $52 on, Monday, February 8th, 2021